NM_003036.4:c.100G>T
Variant summary
Our verdict is Pathogenic. Variant got 16 ACMG points: 16P and 0B. PM1PM2PM5PP3_ModeratePP5_Very_Strong
The NM_003036.4(SKI):c.100G>T(p.Gly34Cys) variant causes a missense change. The variant allele was found at a frequency of 0.000000781 in 1,279,770 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a pathogenic outcome for this variant. Variant has been reported in ClinVar as Pathogenic (★★). Another variant affecting the same amino acid position, but resulting in a different missense (i.e. G34S) has been classified as Likely pathogenic.
Frequency
Consequence
NM_003036.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Pathogenic. Variant got 16 ACMG points.
Transcripts
RefSeq
Ensembl
Frequencies
GnomAD3 genomes Cov.: 31
GnomAD4 exome AF: 7.81e-7 AC: 1AN: 1279770Hom.: 0 Cov.: 31 AF XY: 0.00000158 AC XY: 1AN XY: 632564
GnomAD4 genome Cov.: 31
ClinVar
Submissions by phenotype
Shprintzen-Goldberg syndrome Pathogenic:3
- -
Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SKI protein function. This sequence change replaces glycine with cysteine at codon 34 of the SKI protein (p.Gly34Cys). The glycine residue is moderately conserved and there is a large physicochemical difference between glycine and cysteine. The frequency data for this variant in the population databases is considered unreliable, as metrics indicate insufficient coverage at this position in the ExAC database. This variant has been observed in individual(s) with Shprintzen-Goldberg syndrome (PMID: 23023332, 23103230). In at least one individual the variant was observed to be de novo. ClinVar contains an entry for this variant (Variation ID: 37262). This variant disrupts the p.Gly34 amino acid residue in SKI. Other variant(s) that disrupt this residue have been determined to be pathogenic (PMID: 23023332, 23103230, 24736733). This suggests that this residue is clinically significant, and that variants that disrupt this residue are likely to be disease-causing. For these reasons, this variant has been classified as Pathogenic. -
- -
Inborn genetic diseases Pathogenic:1
- -
not provided Pathogenic:1
- -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at